{"address1": "238 Main Street", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 327 8775", "website": "https://beamtx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease; BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. It also intends to develop BEAM-103, an anti-CD117 monoclonal antibody, and BEAM-104, a cell therapy for development in sickle cell disease and beta-thalassemia; and BEAM-201 and other potential ex vivo CAR-T therapies. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 483, "companyOfficers": [{"maxAge": 1, "name": "Mr. John M. Evans M.B.A.", "age": 46, "title": "CEO & Director", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 1134225, "exercisedValue": 324090, "unexercisedValue": 14027346}, {"maxAge": 1, "name": "Dr. Giuseppe  Ciaramella Ph.D.", "age": 55, "title": "President", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 955550, "exercisedValue": 5805709, "unexercisedValue": 8453914}, {"maxAge": 1, "name": "Dr. Christine P. Bellon J.D., Ph.D.", "age": 58, "title": "Senior VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 680075, "exercisedValue": 437817, "unexercisedValue": 408200}, {"maxAge": 1, "name": "Dr. Amy  Simon M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 715575, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Feng  Zhang Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David R. Liu Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. J. Keith Joung M.D., Ph.D.", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sravan Kumar Emany", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Manmohan  Singh Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gopi  Shanker Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 19.53, "open": 19.45, "dayLow": 17.5501, "dayHigh": 19.45, "regularMarketPreviousClose": 19.53, "regularMarketOpen": 19.45, "regularMarketDayLow": 17.5501, "regularMarketDayHigh": 19.45, "payoutRatio": 0.0, "beta": 1.907, "forwardPE": -3.697065, "volume": 4364506, "regularMarketVolume": 4364506, "averageVolume": 1769738, "averageVolume10days": 2503780, "averageDailyVolume10Day": 2503780, "bid": 17.59, "ask": 17.7, "bidSize": 2, "askSize": 2, "marketCap": 1760678400, "fiftyTwoWeekLow": 17.55, "fiftyTwoWeekHigh": 35.25, "priceToSalesTrailing12Months": 27.719362, "fiftyDayAverage": 26.2726, "twoHundredDayAverage": 25.7044, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 741085248, "profitMargins": 0.0, "floatShares": 67191906, "sharesOutstanding": 99840000, "sharesShort": 12163727, "sharesShortPriorMonth": 9237141, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.121800005, "heldPercentInsiders": 0.01212, "heldPercentInstitutions": 0.79103994, "shortRatio": 5.31, "shortPercentOfFloat": 0.1514, "impliedSharesOutstanding": 99840000, "bookValue": 9.05, "priceToBook": 1.9486188, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -376742016, "trailingEps": -4.58, "forwardEps": -4.77, "enterpriseToRevenue": 11.667, "enterpriseToEbitda": -1.883, "52WeekChange": -0.40582883, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 17.635, "targetHighPrice": 80.0, "targetLowPrice": 26.0, "targetMeanPrice": 49.4, "targetMedianPrice": 42.0, "recommendationMean": 1.58824, "recommendationKey": "buy", "numberOfAnalystOpinions": 15, "totalCash": 850739968, "totalCashPerShare": 10.489, "ebitda": -393643008, "totalDebt": 161424992, "quickRatio": 4.673, "currentRatio": 4.823, "totalRevenue": 63518000, "debtToEquity": 22.006, "revenuePerShare": 0.772, "returnOnAssets": -0.20263, "returnOnEquity": -0.43938, "grossProfits": -304043008, "freeCashflow": -156520992, "operatingCashflow": -347246016, "revenueGrowth": -0.905, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -3.3271399, "financialCurrency": "USD", "symbol": "BEAM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Beam Therapeutics Inc.", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_564610577", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -8.6376, "fiftyDayAverageChangePercent": -0.32876837, "twoHundredDayAverageChange": -8.069399, "twoHundredDayAverageChangePercent": -0.31393066, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1580999400000, "regularMarketChange": -1.8950005, "regularMarketDayRange": "17.5501 - 19.45", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1769738, "fiftyTwoWeekLowChange": 0.08500099, "fiftyTwoWeekLowChangePercent": 0.0048433617, "fiftyTwoWeekRange": "17.55 - 35.25", "fiftyTwoWeekHighChange": -17.615, "fiftyTwoWeekHighChangePercent": -0.4997163, "fiftyTwoWeekChangePercent": -40.582882, "earningsTimestamp": 1740484801, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1730813400, "earningsCallTimestampEnd": 1730813400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.58, "epsForward": -4.77, "epsCurrentYear": -4.66341, "priceEpsCurrentYear": -3.7815676, "longName": "Beam Therapeutics Inc.", "regularMarketChangePercent": -9.703023, "regularMarketPrice": 17.635, "displayName": "Beam Therapeutics", "trailingPegRatio": null}